Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: A pilot gene therapy study in patients with coronary heart disease

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 8, 2009, Pages 790-796

  Yang, Zhi Jian ^a   Xu, Shun Lin ^b   Chen, Bo ^a   Zhang, Shu Lan ^a   Zhang, You Long ^a   Wei, Wang ^a   Ma, Dong Chao ^a   Wang, Lian Sheng ^a   Zhu, Tie Bing ^a   Li, Chun Jian ^a   Wang, Hui ^a   Cao, Ke Jiang ^a   Gao, Wei ^b   Huang, Jun ^a   Ma, Wen Zhu ^a   Wu, Zu Ze ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Coronary heart disease; Cytokines; Endothelial progenitor cell mobilization; Gene therapy; Hepatocyte growth factor

Indexed keywords

ADENOVIRUS VECTOR; CD34 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORONARY STENT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMOGRAPHY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL VEIN; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; HUMAN; INFORMED CONSENT; ISCHEMIC HEART DISEASE; MALE; OUTCOME ASSESSMENT; PATIENT INFORMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS BLOOD; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; AGED; ANTIGENS, CD34; CHEMOKINE CCL2; COLLATERAL CIRCULATION; CORONARY DISEASE; CYTOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HEART CATHETERIZATION; HEMATOPOIETIC STEM CELL MOBILIZATION; HEPATOCYTE GROWTH FACTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; STENTS;

EID: 68549122767     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05151.x     Document Type: Article

References (62)

1. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989 342 : 440 3.
2. Aoki M, Morishita R, Taniyama Y et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 2000 7 : 417 27.
3. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 1992 119 : 629 41.
4. Van Belle E, Witzenbichler B, Chen D et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 1998 97 : 381 90.
5. Balkovetz DF, Lipschutz JH. Hepatocyte growth factor and the kidney. It is not just for the liver. Int. Rev. Cytol. 1999 186 : 225 60.
6. Matsumoto K, Nakamura T. Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001 59 : 2023 38.
7. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med. 1999 5 : 226 30.
8. Yaekashiwa M, Nakayama S, Ohnuma K et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am. J. Respir. Crit. Care Med. 1997 156 : 1937 44.
9. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 1998 101 : 1827 34.
10. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 1997 95 : 2552 8.
11. Nakamura S, Moriguchi A, Morishita R et al. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem. Biophys. Res. Commun. 1998 242 : 238 43.
12. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 2000 106 : 1511 19.
13. Kondo I, Ohmori K, Oshita A et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a 'functional' gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 2004 44 : 644 53.
14. Li Y, Takemura G, Kosai K et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 2003 107 : 2499 506.
15. Shirakawa Y, Sawa Y, Takewa Y et al. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices. J. Thorac. Cardiovasc. Surg. 2005 130 : 624 32.
16. Azuma J, Taniyama Y, Takeya Y et al. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 2006 13 : 1206 13.
17. Miyagawa S, Sawa Y, Taketani S et al. Myocardial regeneration therapy for heart failure: Hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002 105 : 2556 61.
18. Wang W, Yang ZJ, Ma DC et al. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer. Acta Pharmacol. Sin. 2006 27 : 555 60.
19. Yang ZJ, Ma DC, Wang W et al. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther. 2006 13 : 1564 8.
20. Yang Z-J, Wang E, Ma D-C et al. Recruitment of stem cells by hepatocyte growth factor gene via intracoronary transfection in the postinfarction heart failure. Sci. China C Life Sci. 2007 50 : 748 52.
21. Duan HF, Wu CT, Wu DL et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol. Ther. 2003 8 : 467 74.
22. Morelli AE, Coates PT, Shufesky WJ et al. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques:implications for transplantation. Transplantation 2007 83 : 656 62.
23. Tarzami ST, Cheng R, Miao W, Kitsis RN, Berman JW. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J. Mol. Cell. Cardiol. 2002 34 : 209 21.
24. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 1983 51 : 606.
25. Aoki M, Morishita R, Taniyama Y, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by hepatocyte growth factor: Potential gene therapy for ischemic diseases. J. Atheroscler. Thromb. 2000 7 : 71 6.
26. Morishita R, Aoki M, Hashiya N et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004 44 : 203 9.
27. Morishita R, Nakamura S, Hayashi S et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999 33 : 1379 84.
28. Shimamura M, Sato N, Oshima K et al. Novel therapeutic strategy to treat brain ischemia: Overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004 109 : 424 31.
29. Taniyama Y, Morishita R, Aoki M et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: Preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001 8 : 181 9.
30. Taniyama Y, Morishita R, Hiraoka K et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes. Circulation 2001 104 : 2344 50.
31. Wojta J, Kaun C, Breuss JM et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest. 1999 79 : 427 38.
32. Gille J, Khalik M, König V, Kaufmann R. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J. Invest. Dermatol. 1998 111 : 1160 5.
33. Dewald O, Ren G, Duerr GD et al. Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 2004 164 : 665 77.
34. Hayashidani S, Tsutsui H, Shiomi T et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003 108 : 2134 40.
35. Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 2004 165 : 439 47.
36. Salcedo R, Ponce ML, Young HA et al. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000 96 : 34 40.
37. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC. CD34-blood-derived human endothelial cell progenitors. Stem Cells 2001 19 : 304 12.
38. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003 107 : 1164 9.
39. Schmeisser A, Garlichs CD, Zhang H et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 2001 49 : 671 80.
40. Morimoto H, Takahashi M, Izawa A et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ. Res. 2006 99 : 891 9.
41. Mallat Z, Besnard S, Duriez M et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 1999 85 : E17 24.
42. Mostafa Mtairag E, Chollet-Martin S, Oudghiri M et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc. Res. 2001 49 : 882 90.
43. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001 104 : 746 9.
44. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int. J. Cardiol. 2008 124 : 319 25.
45. Schröder JM, Christophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J. Immunol. 1989 142 : 244 51.
46. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 1988 167 : 1547 59.
47. Wang JM, Sica A, Peri G et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler. Thromb. 1991 11 : 1166 74.
48. Yue TL, Wang X, Sung CP et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ. Res. 1994 75 : 1 7.
49. Gerszten RE, Garcia-Zepeda EA, Lim YC et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999 398 : 718 23.
50. Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN. Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently. Biochem. J. 1994 299 : 881 7.
51. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999 85 : 221 8.
52. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 : 964 7.
53. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: Mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 1185 9.
54. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005 106 : 1525 31.
55. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 103 : 2776 9.
56. Forrester JS, Price MJ, Makkar RR. Stem cell repair of infarcted myocardium: An overview for clinicians. Circulation 2003 108 : 1139 45.
57. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000 105 : 1527 36.
58. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: New hope for a broken heart. Circulation 2003 107 : 3093 100.
59. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004 110 : 3213 20.
60. Wojakowski W, Tendera M, Zebzda A et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur. Heart J. 2006 27 : 283 9.
61. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003 101 : 4816 22.
62. Ishizawa K, Kubo H, Yamada M et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem. Biophys. Res. Commun. 2004 324 : 276 80.